文献速递乳腺癌放疗

高危患者每日外照射加速部分乳腺放疗40Gy/10次后的复发模式

Patterns of Recurrence Among Higher-Risk Patients Receiving Daily External Beam Accelerated Partial-Breast Irradiation to 40 Gy in 10 Fractions.
PubMed 文献 · Adv Radiat Oncol · 2019-08-06

单中心连续252例原位或早期浸润性乳腺癌患者接受三维适形外照射加速部分乳腺放疗(APBI),方案统一为40Gy分10次每日照射;中位随访3.9年,97.2%无复发,cautionary组与suitable组同侧乳腺复发率(2.4% vs 1.0%)无显著差异。

要点

  • 按2016年ASTRO共识分组,cautionary组与suitable组同侧乳腺复发率无显著差异。
  • 全组4例同侧乳腺复发(3例suitable、1例cautionary),1例cautionary出现腋窝区域复发。
  • 中位随访3.9年时97.2%患者无复发,局部控制良好。

核心结论

  • 在按指南定义的cautionary组原位或浸润性乳腺癌患者中,每日三维适形40Gy/10次APBI后局部复发少见。
  • 中位随访3.9年,cautionary组与suitable组局部控制无显著差异。

研究设计与样本

  • 单中心2008至2017年连续252例原位或早期浸润性乳腺癌患者接受APBI。
  • 治疗方案统一为三维适形外照射40Gy分10次每日照射。

主要发现

  • 中位随访3.9年时97.2%患者无复发。
  • 4例(总体1.5%;3例suitable、1例cautionary)出现同侧乳腺复发。
  • 1例cautionary患者出现同侧腋窝淋巴结区域复发。
  • cautionary组与suitable组同侧乳腺复发率分别为2.4%与1.0%,差异无统计学意义。

关键数值与推荐

  • APBI风险分组依据2016年美国放射肿瘤学会(ASTRO)共识指南的suitable、cautionary、unsuitable定义。
  • 放疗剂量方案为40Gy分10次每日照射。

临床怎么用

  • 对指南定义为cautionary的早期乳腺癌患者,每日三维适形APBI 40Gy/10次在中位3.9年内局部控制与suitable组相近。
  • 仍需进一步研究明确不同风险组的长期疾病结局。

局限性

  • unsuitable组仅5例且无复发,被排除分析。
  • 中位随访仅3.9年,长期结局尚未明确。
  • 为单中心回顾性连续病例分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The 2016 American Society for Radiation Oncology consensus guidelines for the use of accelerated partial-breast irradiation (APBI) define "suitable," "cautionary," and "unsuitable" populations for this adjuvant breast radiation therapy technique. We sought to determine whether patients in the cautionary group exhibited adverse outcomes after APBI compared with their suitable counterparts. METHODS AND MATERIALS: We identified 252 consecutively treated patients from a single institution with in situ or early-stage invasive breast cancer who underwent APBI between 2008 and 2017. Treatment technique was uniform throughout the population, consisting of 3-dimensional conformal radiation therapy to 40 Gy administered in 10 daily fractions. RESULTS: One hundred seventy-eight patients (70%) were classified as suitable, 69 (27%) as cautionary, and 5 (2.0%) as unsuitable. Because unsuitable patients were few and had no recurrences, they were excluded from analysis. At a median follow-up time of 3.9 years, 97.2% of patients were free of recurrence. Four patients (1.5% overall; 3 suitable and 1 cautionary) experienced ipsilateral in-breast recurrences, and 1 cautionary patient developed an ipsilateral regional recurrence in an axillary lymph node. There was no significant difference in the rate of ipsilateral breast recurrence (2.4% vs 1.0%) between cautionary and suitable groups. CONCLUSIONS: Local recurrences are rare among guideline-defined cautionary patients with in situ or invasive breast cancer treated with APBI delivered via daily 3-dimensional conformal radiation therapy to 40 Gy. At a median follow-up of 3.9 years, no significant differences in local control were noted between cautionary and suitable patient groups. Further study is needed to characterize long-term disease outcomes among various risk groups.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Fitzgerald K, Flynn J, Zhang Z, et al. Patterns of Recurrence Among Higher-Risk Patients Receiving Daily External Beam Accelerated Partial-Breast Irradiation to 40 Gy in 10 Fractions. Adv Radiat Oncol. 2019. PMID: 32051887. doi:10.1016/j.adro.2019.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。